Eurobio Scientific: EchiumBio Holding acquires 2% of share capital
EchiumBio has exceeded the statutory threshold of 2% via purchases of shares on the market, and held 230,956 Eurobio Scientific shares as of February 3, 2023.
' The acquisition of GenDx was made entirely in cash, and the fact that Wietse has joined our capital after only a few months is a very positive signal. says Denis Fortier, CEO of Eurobio Scientific. We were delighted to welcome him to our management team, and it's a great pleasure to have him on board as a partner. It's a strong vote of confidence in our joint project. '
Eurobio Scientific's Board of Directors will recommend the appointment of Wietse Mulder as a director at the next Annual General Meeting.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction